Table 2 Musculoskeletal symptoms
From: Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients
Study (year) | No. of patients | Fatigue (nr/%) | Arthralgia/Myalgia (nr/%) |
|---|---|---|---|
Zheng et al. [37] | 99 | 72 (73%) | 12 (12%) |
Lei et al. [36] | 34 | 25 (73.5%) | 11 (32.4%) |
Mo et al. [60] | 155 | 60 (73.2) | 50 (61.0%) |
Qian et al. [61] | 91 | 40 (43.96%) | 5 (5.49%) |
Ma et al. [62] | 37 | 4 (10.8%) | 4 (10.8%) |
Jin et al. [10] | 651 | 119 (18.2%) | / |
Zheng et al. [11] | 161 | 64 (39.8%) | 18 (11.2%) |
Wang et al. [12] | 80 | 28 (35%) | 19 (23.75%) |
Chen et al. [13] | 203 | 16 (7.9%) | 54 (26.6) |
Zhou et al. [14] | 21 | 5 (23.8%) | 2 (9.5%) |
Lo et al. [15] | 10 | / | 3 (30%) |
Huang et al. [16] | 41 | 18 (44%) | / |
Zhang et al. [17] | 645 | 118 (18.3%) | 71 (11%) |
Chen et al. [18] | 249 | 39 (15.7%) | / |
Feng et al. [19] | 476 | / | 59 (12.4%) |
Chen et al. [20] | 274 | 137 (50%) | 60 (22%) |
Zhang et al. [58] | 140 | 105 (75%) | / |
Lian et al. [47] | 788 | 139 (17.6%) | 91 (11.5%) |
Cai et al. [21] | 298 | 13 (4.3%) | / |
Wan et al. [22] | 135 | / | 44 (32.5%) |
Cao et al. [9] | 102 | 56 (54.9%) | 35 (34.3) |
Wang et al. [32] | 339 | 135 (39.9%) | 16 (4.7%) |
Xu et al. [26] | 62 | / | 32 (52%) |
Zhou et al. [27] | 191 | 44 (23%) | 29 (15%) |
Wu et al. [29] | 201 | 65 (32.3%) | / |
Du et al. [33] | 85 | 50 (58.8%) | 14 (16.5%) |
Wang et al. [35] | 69 | 29 (42%) | 21 (30%) |
Guan et al. [33] | 1099 | 419 (38%) | 164 (15%) |
Goyal et al. [46] | 393 | / | 94 (24%) |
Zhang et al. [24] | 28 | 18 (64%) | 4 (14%) |
Chen et al. [34] | 118 | 19 (16%) | / |
Wang et al. [41] | 1012 | / | 170 (17%) |
Xia et al. [38] | 10 | 3 (30%) | / |
Liang et al. [39] | 1590 | 680 (43%) | 278 (17%) |
Dai et al. [40] | 234 | 31 (13%) | 21 (9%) |
Li et al. [41] | 25 | 17 (68%) | / |
Chu et al. [42] | 54 | 9 (17%) | 3 (6%) |
Qi et al. [43] | 70 | / | 12 (17%) |
Godaert et al. [7] | 17 | 10 (59%) | / |
Ye et al. [28] | 5 | 5 (100%) | / |
Huang et al. [44] | 22 | 5 (23%) | 4 (18%) |
Tian et al. [45] | 262 | 69 (26%) | / |
Huang et al. [8] | 34 | / | 22 (65%) |
Xia et al. [48] | 20 | 1 (5%) | / |
Zhao et al. [49] | 101 | / | 17 (17%) |
Xu et al. [25] | 51 | 2 (4%) | 8 (16%) |
Li et al. [51] | 548 | 258 (47%) | 111 (20%) |
Xu et al. [52] | 90 | 19 (21%) | 25 (28%) |
Lei et al. [54] | 119 | / | 18 (15%) |
Pung et al. [6] | 17 | / | 5 (29%) |
Xu et al. [55] | 50 | 8 (16%) | 8 (16%) |
Escalera-Antezana et al. [59] | 12 | / | 5 (42%) |
Lechien et al. [57] | 417 | 129 (31%) | 246 (59%) |
Dong et al. [56] | 11 | 2 (18%) | 1 (9%) |
Total: 54 | Tot: 12,046 | 3085 (25.6%) | 1866 (15.5%) |